Latest Impairment News

Page 3 of 98
Monster Beverage delivered a strong third quarter, with sales rising 16.7% to US$2.56 billion and international revenue climbing 28.1%. The trade-off was narrower margins as aluminium, freight, fuel, marketing and transformation costs increased.
Victor Sage
Victor Sage
6 Nov 2026
Macquarie Bank’s half-year profit fell 61% to A$1.42 billion after a prior-period A$2.448 billion asset-transfer gain dropped out of the comparison. Its core banking and markets divisions still grew, but credit charges rose and margins remained under pressure.
Victor Sage
Victor Sage
6 Nov 2026
Macquarie Group delivered a 50% rise in first-half profit to A$2.478 billion, with Commodities and Global Markets providing the standout contribution as market activity accelerated. The result also marks Shemara Wikramanayake’s final day as chief executive, with Greg Ward taking over from 7 November.
Claire Turing
Claire Turing
6 Nov 2026
Zoetis lifted its full-year adjusted earnings outlook after a mixed third quarter, but US companion animal revenue fell 8% amid price sensitivity, competition and generic pressure. The animal health group also reported an 18% drop in GAAP net income and a US$89 million impairment charge.
Ada Torres
Ada Torres
5 Nov 2026
Rockwell Automation closed fiscal 2026 with stronger sales, margins, earnings and cash flow, while its software business delivered the fastest growth across the group. The industrial automation company expects further organic growth in fiscal 2027, but its latest numbers also benefited from tariff refunds and an easier comparison with last year’s impairment charges.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Evergy delivered a stronger third quarter, lifted its 2026 adjusted earnings guidance and outlined new power commitments tied to large customers, including a proposed 1.4 GW Digital Realty expansion. The utility also increased its quarterly dividend by 4%.
Maxwell Dee
Maxwell Dee
5 Nov 2026
BD finished fiscal 2026 with higher revenue, adjusted earnings and cash generation, while setting low single-digit growth expectations for the year ahead. Its proposed US$19 billion US investment adds scale to the strategy, but remains tied to milestones and future implementation.
Ada Torres
Ada Torres
5 Nov 2026
Air Products delivered 12% growth in fiscal 2026 adjusted EPS and cut capital spending by US$1.8 billion, while absorbing another US$3.2 billion in charges tied mainly to project exits. The company expects further adjusted earnings growth in fiscal 2027, but its recovery still rests on how successfully it converts a larger backlog into cash flow.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Marimaca Copper ended September with US$126.6 million in cash and US$135.5 million in net working capital, giving the pre-revenue Chilean developer funding visibility for at least the next year. A potential US$17.3 million VAT recovery could add to that liquidity in the first half of 2027, but the Marimaca Project has not yet reached demonstrable technical feasibility or commercial viability.
Maxwell Dee
Maxwell Dee
5 Nov 2026
Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.
Ada Torres
Ada Torres
5 Nov 2026
McKesson delivered a strong fiscal second quarter, with revenue up 8% and adjusted diluted EPS rising 18%. The healthcare distributor lifted its full-year adjusted EPS guidance while expanding its specialty-care portfolio through new investments and acquisitions.
Ada Torres
Ada Torres
5 Nov 2026
National Australia Bank’s FY2026 profit fell 9.1% to $6.143 billion as higher credit impairment charges and a $1.347 billion software amortisation charge outweighed stronger lending income. The dividend held at 170 cents per share, while capital buffers improved and management flagged a sharper focus on efficiency and risk control.
Victor Sage
Victor Sage
5 Nov 2026

Browse the archive

Full archive